Genmab A/S (GMAB) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Genmab A/S (GMAB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow (Dkr536.00 Million) in capital expenditures (Dkr2.00 Million). See GMAB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
Dkr536.00 Million
DKK
Capital Expenditures
Dkr2.00 Million
DKK
Data as of
Sep 2025
Most recent filing
Genmab A/S Capital Reinvestment Ratio (2007–2024)
This chart tracks Genmab A/S's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Genmab A/S (2007–2024)
Year-by-year Capital Reinvestment Ratio for Genmab A/S from 2007 to 2024. For live market cap and broader valuation context, see Genmab A/S (GMAB) total market value.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | Dkr7.77 Billion | Dkr187.00 Million | ▼ -52.8% |
| 2023 | 0.05x | Dkr7.38 Billion | Dkr376.00 Million | ▼ -37.1% |
| 2022 | 0.08x | Dkr3.91 Billion | Dkr317.00 Million | ▼ -28.4% |
| 2021 | 0.11x | Dkr2.23 Billion | Dkr252.00 Million | ▲ +137.0% |
| 2020 | 0.05x | Dkr6.43 Billion | Dkr307.00 Million | ▼ -43.0% |
| 2019 | 0.08x | Dkr1.33 Billion | Dkr111.00 Million | ▼ -82.2% |
| 2018 | 0.47x | Dkr1.01 Billion | Dkr477.37 Million | ▲ +744.5% |
| 2017 | 0.06x | Dkr1.59 Billion | Dkr88.51 Million | ▼ -44.9% |
| 2016 | 0.10x | Dkr327.72 Million | Dkr33.11 Million | ▼ -76.8% |
| 2015 | 0.43x | Dkr311.45 Million | Dkr135.39 Million | ▼ -23.6% |
| 2014 | 0.57x | Dkr132.67 Million | Dkr75.44 Million | ▲ +348.2% |
| 2012 | 0.13x | Dkr70.92 Million | Dkr9.00 Million | ▲ +236.5% |
| 2010 | 0.04x | Dkr268.17 Million | Dkr10.11 Million | ▲ +48.5% |
| 2007 | 0.03x | Dkr505.90 Million | Dkr12.84 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow